New business models for clinical development and manufacturing require strategic partnerships among researchers, manufacturers and payers to fully realize the commercial opportunities.
Report findings provide insight into technological innovations and trends in drug development
Knect365 Life Sciences has released a report offering unique insights into the awareness, perceptions and i...
Other content in this Stream
Starting a biotech company: What every entrepreneur needs to know
Just released: The Biotech Startup Manual. This report distills the insights, wisdom, and inspiration from a carefully selected group of industry pioneers on what it truly takes to start a...
How stakeholder insight adds value to your asset and drug development program
Thinking early about market access is something many small and virtual biotech firms don’t automatically think to do, but should. Read more »
How to find biotech startup cash, with or without traditional VCs
Guest post by Luke Timmerman, founder and editor of the Timmerman Report, and a regular contributor to Forbes and STAT News. Skim the headlines, and you might get the impression that the biotech...
EBD Academy brings executive-level leadership skills to you
Executive education is a critical component of business effectiveness. Business development senior management, executive management, and management teams perform at the highest level of an...
Bayer East Coast Innovation Center Head reveals early strategic advantage is something pharma wants from biotech startups
Partnering Insight recently had the pleasure of speaking with Dr. Chandra Ramanathan, Head of the East Coast Innovation Center at Bayer, whose mission is building an innovative product portfolio...
Boston is arguably the heart of biotech. But who makes it so? Have your say.
By the end of this year, for the first time, patients with certain deadly types of blood cancer might have a new option, CAR-T cell therapy, to prolong their life. Immunotherapy could further...
Biotech Startups: Land and conduct a successful investor meeting
Biotech startup companies face many challenges, but one of the most common is landing and conducting meetings with potential investors. The following are pieces of advice from investors on what...
How can startup companies get noticed by potential investors and partners?
Access the industry's premier life science partnering event, BioPharm America™ in Boston September 26–27, 2017, to connect with strategic partners and get your innovation funded. No other event combin
Where are they now? EpiAxis Therapeutics channels successes into scientific and business development
EpiAxis Therapeutics is channeling its success at BioPharm America™’s Startup Day into success at the business and scientific levels. Since finishing first for best “investment pitch quality and...
Where are they now? Cocoon Biotech planning tox studies
Recognition from a high profile organization like the BioPharm America™ conference has been tremendous for Cocoon,” Ailis Tweed-Kent, MD, founder and CEO of Cocoon Biotech says. Winning the...
Where are they now? For Virvio, it’s all about visibility
When Virvio participated in BioPharm America™’s Startup Day pitch contest in 2016, the company had been operational less than one year. It had three employees and was operating under grants from...
Bruce Levine is a man you can thank for your future cell therapy
To call Bruce Levine, PhD, an innovator in the cell and gene therapy space is a gross understatement. He is known for his groundbreaking work in the development and use of synthetic immune cells...
ChinaBio® Partnering Forum 2017: Rapid change: Good times for pharma?
Everything in China seems to be on the fast track. This is especially true in the pharma industry, where new announcements affecting regulations, pricing, and reimbursement are occurring on nearly a d
ChinaBio® Partnering Forum 2017: Funding drug development in China through VCs and partnerships
Western and China companies are leveraging the significant funding and support available in China to develop their assets more cost effectively and efficiently. 2016 set another record in VC funds rai
ChinaBio® Partnering Forum 2017: HitGen aids China drug discovery with DNA library
Wei Chen, head of R&D for Chengdu-based HitGen describes to Scrip’s Brian Yang how the Chinese startup partners with multinationals to speed up new drug development in China, and planned IND filing fo
ChinaBio® Partnering Forum 2017: Sirnaomics prioritizes China in parallel with US RNAi development
Alan Y. Lu, Executive VP of Sirnaomics, discusses with Scrip’s Brian Yang how the US-China hybrid looks to develop RNAi therapies simultaneously in the two countries. RNAi is relatively new in China,
ChinaBio® Partnering Forum 2017: China's EpimAb hunts for novel biologics with funding, partnership
Dr. Wu Chengbin, CEO and founder of Shanghai-based EpimAb Biotherapeutics discusses with Scrip’s Brian Yang how the startup's preparatory platform will develop next-generation bispecific antibodies.
ChinaBio® Partnering Forum 2017: China's HEC Pharm enters America with novel IPF treatment
Tommy Lin, head of Business Development and Global Licensing for HEC Pharm outlines for Scrip’s Brian Yang how the Chinese domestic drug company looks to develop its liver drug in the US. On May 2, t
ChinaBio® Partnering Forum 2017: ConSynance tests waters in China with differentiated NASH asset
Dr. Shuang Liu, president and co-founder of upstate New York-based ConSynance Therapeutics discusses with Scrip’s Brian Yang the startup's plan to develop and commercialize its multiple assets in vari
ChinaBio® Partnering Forum 2017: Roche looks to real-world data and IT to drive partnering in China